![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print April 21, 2003
Internal Medicine, Seoul National University College of Medicine, Seoul 110-744
Corresponding Author: csshin{at}plaza.snu.ac.kr
Mesenchymal cells are able to differentiate into several distinct cell types, including osteoblasts and adipocytes. The commitment to a particular lineage may be regulated by specific transcription factors. Peroxisome proliferator activated receptor ã (PPARã) acting in conjunction with C/EBPá has been suggested as a key regulator of adipogenic differentiation. Previous studies have shown that the activation of PPARã in osteoblasts suppresses osteoblast differentiation and the expression of osteocalcin, one of the osteoblast-specific proteins. However, the mechanism of this inhibition remains unclear. We investigated the effect of PPARã activation on the expression of osteocalcin and analyzed the underlying molecular mechanism. Mouse osteoblastic cell line MC3T3-E1 cells express PPARã, which is transcriptionally active, whereas rat osteosarcoma cell line, ROS 17/2.8 does not. Treatment of MC3T3-E1 osteoblasts and ROS 17/2.8 cells stably transfected with PPARã2 with the PPARã activator, 15-deoxy-Ä12,14 prostaglandin J2 (15d-PGJ2), inhibited the mRNA expression of osteocalcin and Runx2, the latter of which is a key transcription factor in the osteoblastic differentiation. These decreased expressions of osteocalcin and Runx2 were partly explained by the decreased abundance of Runx2 resulting from the suppressed transcription from Runx2 promoter. However, in addition to this indirect effect, the activation of PPARã by 15d-PGJ2 directly suppressed the Runx2-mediated induction of osteocalcin promoter activity and of the activity of the artificial promoter p6OSE2, which contained six tandem copies of the OSE2 element, the Runx2-binding promoter sequence. This inhibition was found to be mediated by a physical interaction between PPARã and Runx2 and the subsequent repression of the transcriptional activity of the OSE2 sequence. Thus, this study demonstrates that the activation of PPARã inhibits osteocalcin expression both by suppressing the expression of Runx2 and by interfering with the transactivation ability of Runx2.
J. Biol. Chem, 10.1074/jbc.M211610200
Submitted on November 14, 2002
Revised on April 15, 2003
Accepted on April 21, 2003
Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
X. Li, M. Huang, H. Zheng, Y. Wang, F. Ren, Y. Shang, Y. Zhai, D. M. Irwin, Y. Shi, D. Chen, et al. CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation J. Cell Biol., October 21, 2008; 181(6): 959 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kang, C. N. Bennett, I. Gerin, L. A. Rapp, K. D. Hankenson, and O. A. MacDougald Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein {alpha} and Peroxisome Proliferator-activated Receptor {gamma} J. Biol. Chem., May 11, 2007; 282(19): 14515 - 14524. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kim, S. W. Cho, S. J. Her, J. Y. Yang, S. W. Kim, S. Y. Kim, and C. S. Shin Retrovirus-Mediated Gene Transfer of Receptor Activator of Nuclear Factor-{kappa}B-Fc Prevents Bone Loss in Ovariectomized Mice Stem Cells, July 1, 2006; 24(7): 1798 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Shin, M. J. Jeon, J.-Y. Yang, S.-J. Her, D. Kim, S. W. Kim, and S. Y. Kim CCAAT/enhancer-binding protein {delta} activates the Runx2-mediated transcription of mouse osteocalcin II promoter. J. Mol. Endocrinol., June 1, 2006; 36(3): 531 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rodan and A. R. Rodan The Family of Osteoblast Transcription Factors is Growing IBMS BoneKEy, October 1, 2005; 2(10): 12 - 15. [Full Text] [PDF] |
||||
![]() |
C. N. Bennett, K. A. Longo, W. S. Wright, L. J. Suva, T. F. Lane, K. D. Hankenson, and O. A. MacDougald Regulation of osteoblastogenesis and bone mass by Wnt10b PNAS, March 1, 2005; 102(9): 3324 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-S. Xiao, A. B. Hjelmeland, and L. D. Quarles Selective Deficiency of the "Bone-related" Runx2-II Unexpectedly Preserves Osteoblast-mediated Skeletogenesis J. Biol. Chem., May 7, 2004; 279(19): 20307 - 20313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |